Clinical Trial Update: Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial called PROMOTE is evaluating a polypill and RiscOMeter to prevent stroke and cognitive impairment; recruitment is in progress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Stroke

Drugs mentioned

• Polypill
• RiscOMeter (Risk assessment device)

Snippet

Sponsor: Hospital Moinhos de Vento | Conditions: Stroke, Cognitive Decline | Phase 3 | Status: RECRUITING